Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial

BACKGROUND: Patients with non-alcoholic fatty liver disease (NAFLD) as well as type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular diseases (CVD). Omega-3 supplementation has been proposed as a possible strategy for management of cardiometabolic risk. Cardiometabolic indices can...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangouni, Abbas Ali, Orang, Zahra, Mozaffari-Khosravi, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672492/
https://www.ncbi.nlm.nih.gov/pubmed/34911587
http://dx.doi.org/10.1186/s40795-021-00490-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672492/
https://www.ncbi.nlm.nih.gov/pubmed/34911587
http://dx.doi.org/10.1186/s40795-021-00490-8

Ejemplares similares